…global economy. The agreement aims to strengthen economies and foster free trade. Twenty-five percent of the exported U.S. health products were exported to the TPP region in 2015, and some…
…global economy. The agreement aims to strengthen economies and foster free trade. Twenty-five percent of the exported U.S. health products were exported to the TPP region in 2015, and some…
…and see. References Williams, R., Graboyes, R., and Thierer, A. (October 2015). US Medical Devices: Choices and Consequences. Mercatus Cetner, George Mason University. Accessed January 4, 2017. Retrieved from https://www.mercatus.org/system/files/Williams-Medical-Devices.pdf…
…and see. References Williams, R., Graboyes, R., and Thierer, A. (October 2015). US Medical Devices: Choices and Consequences. Mercatus Cetner, George Mason University. Accessed January 4, 2017. Retrieved from https://www.mercatus.org/system/files/Williams-Medical-Devices.pdf…
As if things couldn’t get worse for Theranos, the news came today that the company is cutting nearly 41% of its positions (155 employees), with only 220 staff remaining. According…
As if things couldn’t get worse for Theranos, the news came today that the company is cutting nearly 41% of its positions (155 employees), with only 220 staff remaining. According…
The latest rumors following FDA Commissioner Robert Califf, M.D.’s interview with The Washington Post, is that he may leave FDA under President-elect Donald Trump’s administration. Califf said that Trump’s transition…
The latest rumors following FDA Commissioner Robert Califf, M.D.’s interview with The Washington Post, is that he may leave FDA under President-elect Donald Trump’s administration. Califf said that Trump’s transition…
…consolidation continues Slow pricing growth due to GPOs, value analysis committees and other buying committees R&D remains strong, with device manufacturers spending about 7% of revenue to fund research Cybersecurity…
…consolidation continues Slow pricing growth due to GPOs, value analysis committees and other buying committees R&D remains strong, with device manufacturers spending about 7% of revenue to fund research Cybersecurity…
…the confusion that often ensues among healthcare providers and patients, CDRH has changed how it communicates device recalls. As of January 3, the center is posting recall information right when…
…the confusion that often ensues among healthcare providers and patients, CDRH has changed how it communicates device recalls. As of January 3, the center is posting recall information right when…
…today is highly sophisticated, feature-rich and has a combination of advanced electronics and software, making it increasingly complex. Thus, any operational or functional failure of such medical equipment can be…
…today is highly sophisticated, feature-rich and has a combination of advanced electronics and software, making it increasingly complex. Thus, any operational or functional failure of such medical equipment can be…
FDA has updated its latest list of final guidances that are a priority for FY 2017. The A-list includes the guidances that FDA fully intends to publish, and the B-list…
FDA has updated its latest list of final guidances that are a priority for FY 2017. The A-list includes the guidances that FDA fully intends to publish, and the B-list…
FDA has released a final guidance document that clarifies the agency’s recommendations for recommendations of how medical device companies should management postmarket cybersecurity vulnerabilities. The guidance, Postmarket Management of Cybersecurity…
FDA has released a final guidance document that clarifies the agency’s recommendations for recommendations of how medical device companies should management postmarket cybersecurity vulnerabilities. The guidance, Postmarket Management of Cybersecurity…
…Vietnam, and market experts predict that other pharmaceutical companies will follow, potentially leading to more merger and acquisition opportunities of Vietnamese drug companies by foreign companies. A variety of factors…
…Vietnam, and market experts predict that other pharmaceutical companies will follow, potentially leading to more merger and acquisition opportunities of Vietnamese drug companies by foreign companies. A variety of factors…
